학술논문

Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins
Document Type
Article
Source
In: Scientific Reports. (Scientific Reports, December 2021, 11(1))
Subject
Language
English
ISSN
20452322